The Office of Cooperative Research Hosts: "Accelerating Your Biotech Idea: How to Apply for Blavatnik Fund and ABCT Programs"

Join us on September 11th for an info session on how to get your idea funded!

Lunch will be provided.

The Blavatnik Fund for Innovation at Yale supports Yale faculty in the commercialization of applied research and technology in the life sciences. A significant obstacle to the development of early-stage university discoveries is the lack of funding for the proof-of-concept and validation studies needed to demonstrate commercial potential. To overcome this barrier, the Fund provides funding and business development support to help validate nascent technologies and identify potential industry partners to advance these technologies to the marketplace.

The Fund seeks to support innovative, investigator-initiated research aimed at extending preliminary observations, with proof-of-concept and the generation of robust intellectual property as key objectives. The Fund is designed to accommodate projects of varying magnitude, as appropriate. Its primary goal is to advance technologies to the point where additional support from industry and/or technology transfer is achieved.

Supported projects may include such areas as therapeutics, diagnostics/biomarkers, medical devices, or research instruments, among others. The expected goal of completed projects will be partnerships with industry, through licenses to existing biopharmaceutical companies and startup firms (some launched from the Fund-supported technology) or via major industry-sponsored research agreements. It is expected that these alliances will lead to additional industry-sponsored research support. The Fund is structured as a sustainable, “evergreen” program. Twenty percent of the revenue from successfully licensed technologies will be contributed back to the Blavatnik Fund for Innovation at Yale to support ongoing and future projects.

Applications for the Blavatnik Fund for Innovation at Yale will open October 1, 2019, and will be accepted up until 5pm on Oct 28, 2019

Accelerator for Biosciences in Connecticut, ABCT, is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBA's and MD's interested to form new ventures in biosciences.

Accelerator for Biosciences in Connecticut encourages applications from IP based inventions. You do not need a company formed to apply to ABCT. ABCT features a mini-MBA curriculum, expert coaching, networking, mentorship, pitch preparation, access to professional colleagues as Venture Advisors from the program Corporate Supporters including Purdue, Kaneka, Pfizer, Marcum, Shipman & Goodwin, WSGR, Wiggin and Dana and AON and access to the NYC biosciences community including foundations and investors.

Applications for the Accelerator for Biosciences in Connecticut are available now!